No news, no filings, nothing negative -- good opportunity
There was no SEC filing, nothing negative in the CEO's blog, nor was there any negativity regarding electroporation to cause this session drop. There was one transaction at over 100,000 shares sold, which caused the stock to fall 5%. The rest was a domino effect. When events such as this happens, it always bounces back, as there is nothing substantial to support the decline. Buy on the dip, ONCS is trending higher long-term.
Just some traders making a small profit. The blog by Punit was very encouraging. This stock could easily be a 10-40 times it's current market cap with a successful melanoma launch, when I don't know but would sure be worth waiting for. Bios usually have market caps of about 5 times sales, you do the math.